Molecular Autopsy Study
ConditionSudden Unexplained Death
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 45
SponsorScripps Translational Science Institute
About this trial
This study seeks to incorporate genetic testing into the postmortem examination of cases of sudden unexplained death.
Eligibility criteria
Qualifiers
Index case age between birth - 45 years
Clinical presentation of sudden / unexplained death (believed to be cardiac in nature OR secondary to a massive unprovoked pulmonary embolism with no prior diagnosis of prothrombotic disease)
Disqualifiers
Premature death secondary to murder, suicide or external causal event
Premature death thought secondary to known chronic comorbid medical condition
Premature death thought secondary to end-organ failure (kidney, liver, lung) other than heart
Previously diagnosed with hypertrophic cardiomyopathy (HCM)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov